Citigroup
C
Chevron
CVX
The Kraft Heinz
KHC
DaVita
DVA
Apple
AAPL
US Stock MarketDetailed Quotes
KAPA Kairos Pharma
- 1.730
- -0.040-2.26%
Close Jan 17 16:00 ET
- 1.770
- +0.040+2.31%
Post 20:01 ET
22.22MMarket Cap-8.24P/E (TTM)
2.080High1.666Low691.92KVolume1.850Open1.770Pre Close1.28MTurnover44.64%Turnover RatioLossP/E (Static)12.85MShares4.00052wk High6.68P/B2.68MFloat Cap0.85152wk Low--Dividend TTM1.55MShs Float4.000Historical High--Div YieldTTM23.39%Amplitude0.851Historical Low1.854Avg Price1Lot Size
About Kairos Pharma Company
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
Company Profile
SymbolKAPA
Company NameKairos Pharma
Listing DateSep 16, 2024
Founded2013
CEODr. John S. Yu,M.D.
MarketAMEX
Employees3
Fiscal Year Ends12-31
Address2355 Westwood Boulevard,Suite 139
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90064
Phone1-310-948-2356
Websitehttp://kairospharma.com
Company Executives
- Name
- Position
- Salary
- Dr. John S. Yu,M.D.
- Chairman of the Board and Chief Executive Officer
- --
- Neil Bhowmick
- Chief Scientific Officer
- --
- Doug Samuelson
- Chief Financial Officer
- --
- Ramachandran Murali, PhD
- Vice President of Research and Development
- --
- Dr. Rahul Singhvi, Sc.D.
- Director
- --
- Hyun W. Bae, M.D.
- Independent Director
- --
- Dr. Hansoo Michael Keyoung, M.D.,PhD
- Independent Director
- --
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
